Sars-Cov-2 myocarditis in a patient with a negative nasopharyngeal swab. First case described in Costa Rica
DOI:
https://doi.org/10.37615/retic.v4n3a11Keywords:
Myocardial injury, myocarditis, COVID 19.Abstract
Myocarditis associated with SARS-CoV-2 disease is known and several cases have been reported worldwide. The pathophysiology of COVID-19-related myocarditis is believed to be a combination of direct viral damage to the myocardium and cardiac damage due to the host’s immune response. Clinical findings include changes in the electrocardiogram, alteration of cardiac biomarkers, and cardiac function impairment. Within the diagnostic work, coronary artery disease must be ruled out, and cardiac imaging techniques such as cardiac magnetic resonance should be used, allowing the Lake Louis criteria, characteristic of myocarditis, to be identified.
Downloads
Metrics
References
Zhu N., Zhang D., Wang W. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
Mahase E. Covid-19: death rate is 0.66% and increases with age, study estimates. BMJ. 2020;369:m1327.
Zeng J.-H., Liu Y.-X., Yuan J. First case of COVID-19 infection with fulminant myocarditis complication: case report and insights. Published online April 10. Infection. 2020 doi: https://doi.org/10.1007/s15010-020-01424-5
Inciardi R.M., Lupi L., Zaccone G. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:819–824.
Kim I.-C., Kim J.Y., Kim H.A., Han S. COVID-19-related myocarditis in a 21-year-old female patient. Eur Heart J. 2020;41:1859.
Sala S., Peretto G., Gramegna M. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. 2020;41:1861–1862.
https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/
Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819-824.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 José Alejandro Sanabria-Garita, Carlos Eduardo Bolaños Gómez, Juan Carlos Vega-Chaves, Edgar Fuentes-Molina, Alejandro Vallecillo-Torres
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
